Daily Treatment with SMTC1100, a Novel Small Molecule Utrophin Upregulator, Dramatically Reduces the Dystrophic Symptoms in the mdx Mouse-Reference-Cited by-同舟云学术

Daily Treatment with SMTC1100, a Novel Small Molecule Utrophin Upregulator, Dramatically Reduces the Dystrophic Symptoms in the mdx Mouse

Published:2011-05-06 Issue:5 Volume:6 Page:e19189
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Tinsley Jonathon M.,Fairclough Rebecca J.,Storer Richard,Wilkes Fraser J.,Potter Allyson C.,Squire Sarah E.,Powell Dave S.,Cozzoli Anna,Capogrosso Roberta F.,Lambert Adam,Wilson Francis X.,Wren Stephen P.,De Luca Annamaria,Davies Kay E.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference21 articles.

1. Therapeutics for Duchenne muscular dystrophy: current approaches and future directions.;S Bogdanovich;J Mol Med,2004

2. Pharmacological strategies for muscular dystrophy.;TS Khurana;Nat Rev Drug Discov,2003

3. The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy.;CM McDonald;Muscle Nerve

4. 24 week follow-up data from a phase I/IIa extension study of PRO051/GSK2402968 in subjects with Duchenne muscular dystrophy.;NM Goemans;Neuromusc Disord,2010

5. Current progress and preliminary results with the systemic administration trial of AVI-4658, a novel phosphorodiamidate morpholino oligomer (PMO) skipping dystrophin exon 51 in Duchenne muscular dystrophy (DMD).;SB Shrewsbury;Neuromuscular Disorders,2010

Cited by 151 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Upregulation of utrophin improves the phenotype of Duchenne muscular dystrophy hiPSC-derived CMs;Molecular Therapy - Nucleic Acids;2024-09

2. Molecular and Biochemical Therapeutic Strategies for Duchenne Muscular Dystrophy;Neurology International;2024-07-05

3. Targeted genetic therapies for inherited disorders that affect both cardiac and skeletal muscle;Experimental Physiology;2023-12-14

4. Dystrophin- and Utrophin-Based Therapeutic Approaches for Treatment of Duchenne Muscular Dystrophy: A Comparative Review;BioDrugs;2023-11-02

5. Resolution of fibrosis in mdx dystrophic mouse after oral consumption of N-163 strain of Aureobasidium pullulans produced β-glucan;Scientific Reports;2023-10-09